Article Details

Alector, GSK Team Up to Develop 2 Antibody Treatments for ALS

Retrieved on: 2021-07-06 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Alector, GSK Team Up to Develop 2 Antibody Treatments for ALS. View article details on hiswai:

Excerpt

Low levels of progranulin, known as PGRN, which is a key regulator of immune responses and nerve cell survival in the brain, have been associated ...

Article found on: alsnewstoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up